114 related articles for article (PubMed ID: 35385784)
21. Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes.
Adra J; Lundstedt D; Killander F; Holmberg E; Haghanegi M; Kjellén E; Karlsson P; Alkner S
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):285-295. PubMed ID: 31212042
[TBL] [Abstract][Full Text] [Related]
22. Relevant impact of central pathology review on nodal classification in individual breast cancer patients.
Vestjens JHMJ; Pepels MJ; de Boer M; Borm GF; van Deurzen CHM; van Diest PJ; van Dijck JAAM; Adang EMM; Nortier JWR; Rutgers EJT; Seynaeve C; Menke-Pluymers MBE; Bult P; Tjan-Heijnen VCG
Ann Oncol; 2012 Oct; 23(10):2561-2566. PubMed ID: 22495317
[TBL] [Abstract][Full Text] [Related]
23. Hypofractionated Adjuvant Radiation Therapy Is Effective for Patients With Lymph Node-Positive Breast Cancer: A Population-Based Analysis.
Koulis TA; Nichol AM; Truong PT; Speers C; Gondara L; Tyldesley S; Lohrisch C; Weir L; Olson RA
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1150-1158. PubMed ID: 32721421
[TBL] [Abstract][Full Text] [Related]
24. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients.
Querzoli P; Pedriali M; Rinaldi R; Lombardi AR; Biganzoli E; Boracchi P; Ferretti S; Frasson C; Zanella C; Ghisellini S; Ambrogi F; Antolini L; Piantelli M; Iacobelli S; Marubini E; Alberti S; Nenci I
Clin Cancer Res; 2006 Nov; 12(22):6696-701. PubMed ID: 17121888
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
[TBL] [Abstract][Full Text] [Related]
26. Outcomes in Patients with pT1-T2, pN0-N1 Breast Cancer After Conservative Surgery and Whole-breast Radiotherapy.
Trignani M; DI Carlo C; Cefalogli C; Nuzzo M; Ursini LA; Caravatta L; Perrotti F; DI Nicola M; Pamio A; Genovesi D
In Vivo; 2017 Jan; 31(1):151-158. PubMed ID: 28064235
[TBL] [Abstract][Full Text] [Related]
27. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement.
Diao K; Andring LM; Barcenas CH; Singh P; Carisa Le-Petross H; Reed VK; Reddy JP; Bloom ES; Ahmad NR; Mayo LL; Perkins GH; Mitchell MP; Nead KT; Tereffe W; Smith BD; Woodward WA
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):66-74. PubMed ID: 34710521
[TBL] [Abstract][Full Text] [Related]
28. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort
Houvenaeghel G; de Nonneville A; Cohen M; Chopin N; Coutant C; Reyal F; Mazouni C; Gimbergues P; Azuar AS; Chauvet MP; Classe JM; Daraï E; Martinez A; Rouzier R; de Lara CT; Lambaudie E; Barrou J; Goncalves A
ESMO Open; 2021 Jun; 6(3):100151. PubMed ID: 33984674
[TBL] [Abstract][Full Text] [Related]
29. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
[TBL] [Abstract][Full Text] [Related]
30. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
[TBL] [Abstract][Full Text] [Related]
31. Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes.
Kim SW; Chun M; Han S; Jung YS; Choi JH; Kang SY; Yim H; Kang SH
Cancer Res Treat; 2017 Apr; 49(2):484-493. PubMed ID: 27554479
[TBL] [Abstract][Full Text] [Related]
32. [Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].
Le Scodan R; Bruant S; Selz J; Bollet MA; Daveau C; de la Lande B; Lerebours F; Labib A; Stevens D
Cancer Radiother; 2011 Dec; 15(8):675-82. PubMed ID: 21831686
[TBL] [Abstract][Full Text] [Related]
33. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
[TBL] [Abstract][Full Text] [Related]
34. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Daveau C; Stevens D; Brain E; Berges O; Villette S; Moisson P; Gardner M; De la Lande B; Lasry S; Labib A; Le Scodan R
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):337-42. PubMed ID: 20171795
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
[TBL] [Abstract][Full Text] [Related]
36. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
37. [Is there a rationale for regional node irradiation in pN1mi and pN0(i+) breast tumours?].
Tallet A; Resbeut M
Cancer Radiother; 2015 Jun; 19(4):284-7. PubMed ID: 26006762
[TBL] [Abstract][Full Text] [Related]
38. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy.
Lanning RM; Morrow M; Riaz N; McArthur HL; Dang C; Moo TA; El-Tamer M; Krause K; Siu C; Hsu M; Zhang Z; Pei X; McCormick B; Powell SN; Ho A
Ann Surg Oncol; 2015 Aug; 22(8):2517-25. PubMed ID: 25564167
[TBL] [Abstract][Full Text] [Related]
40. The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.
van Maaren MC; Bretveld RW; Jobsen JJ; Veenstra RK; Groothuis-Oudshoorn CG; Struikmans H; Maduro JH; Strobbe LJ; Poortmans PM; Siesling S
Br J Cancer; 2017 Jul; 117(2):179-188. PubMed ID: 28588320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
